This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The heart and vascular medication market continues to be a critical focus area for pharmacompanies, with billions of dollars in sales generated annually. In this blog, we take a closer look at the top 10 heart and vascular medications based on recent sales data. Eliquis (Apixaban) Eliquis 2023 sales :$12.21
The role of pharmasales reps is an incredibly important part of this lifecycle from initial research to point of sale and distribution, with reps connecting the groundbreaking research and technology of pharmacompanies with healthcare professionals and medical establishments.
Further, 62% of HCPs said that the most significant area where pharma representatives can add value is, by understanding the needs of HCPs and sharing only relevant content with them to make the interactions more insightful. At the same time, marketing emails are among the top 5 channels used by pharmacompanies to engage HCPs.
Eversana’s suite of commercialisation tools for pharmacompanies will soon have a new component – cognitive behavioural training tools designed to improve the performance of sales representatives. The post Eversana aims athletes’ mental coaching at pharmasales reps appeared first on.
An unexpected benefit of healthcare professional (HCP) engagement going digital in 2020 is that sales teams have more opportunities to spend quality time with doctors. Read the How Emerging Pharma Can Launch and Scale Content Faster eBook from Veeva in full.
At least seven more pharmacompanies and a federation of pharma manufacturers have approached the Delhi High Court against the Central Government’s order in the beginning of June prohibiting manufacturing, distribution and sale of 14 fixed dose combinations (FDCs) licensed prior to the year 1988.
The Delhi High Court has granted ten days’ time to the Government of India and the nation’s drug regulator to file a counter affidavit on the petitions filed by almost 28 pharmacompanies against the order prohibiting manufacturing, distribution and sale of 14 FDCs licensed prior to the year 1988, in the beginning of June. […]
So too are the sales figures. billion in vaccine sales this year. This sales strategy contrasts to AstraZeneca, which pledged to provide its vaccine on a not-for-profit basis until the pandemic ends. For the first half of 2021, sales on AZ’s vaccine, sold as Vaxzevria and Covishield, reached $1.2 Katrina Megget reports.
Pharma Executive says “just as HCPs are being forced to embrace telemedicine, pharmacompanies are also being forced to embrace virtual interactions with HCPs. COVID-19 has stopped almost all in-person detailing by sales reps” . Will digital replace the sales force?
” To me, an enormous warning flag went up when the VP of Market Access was on a call with the commercial organization (sales). At 99% of pharmacompanies, that's a huge no-no. ” To me, an enormous warning flag went up when the VP of Market Access was on a call with the commercial organization (sales).
The post The benefits of being a family-run pharmacompany appeared first on. Giacomo Chiesi is head of global rare diseases at the international healthcare firm Chiesi Group, where he leads the team developing and commercialising treatments for rare and ultra-rare diseases.
SUMMARY: Those working in pharma know that ageism exists, especially in the sales force. Pharma has been purging older employees for some time, and when you reach the magic age of 50+, you’re going to be pushed to take “early retirement.”
Ipsen has started exclusive negotiations that could see its global consumer health business sold to fellow French pharmacompany Mayoly Spindler later this year. The post Ipsen plans sale of consumer health business for €350m appeared first on.
OPENING: Pharmacompanies are starting to embrace digital marketing forced, in large part, by changes brought on by the pandemic. interactions with pharmaceutical company employees by video call/conferencing during the previous 7 days, the same rate as a month earlier. The Challenges for Pharma. no pharmaceutical reps).
Pharmacompanies have improved how they engage with healthcare providers as a result of COVID-19, according to a new survey of HCPs. This has resulted in pharmacompanies being more relevant and providing more value in closing the care gap, the report says. The impact on launch.
Pharmasales reps are rewarded in a very indirect way. That has always been difficult to measure, especially outside the US where no HCP level (only brick) prescription data is available and despite this the sales force has been by far the biggest (and most expensive) channel. About Exeevo. appeared first on.
In pharma, growth depends on new products with hefty price tags when over 80% of voters want lower costs for their prescription drugs. Biogen’s failure should be a warning to other pharmacompanies. Now Biogen is a shell of a company selling off assets to survive. It should be a warning to other pharmacompanies.
About the only thing I agree with is their assessment of sales reps. “What we are feeling now are the effects of a historic over-reliance on the sales rep channel to the detriment of digital channels. Do you want to know the biggest challenge facing pharmacompanies right now? Now that’s really eye-opening!
Walk into any corporate pharma HQ, and you’re likely to see a mission statement that’s pure b t about how patients come first. We all know that Wall Street and sales come well before patients. Just look at any pharma product website that is nothing but a sales brochure in a majority of cases. Want proof?
Executives at Pfizer, Merck, and Novartis are looking for promising drugs to add to their pipelines and replenish sales as top-selling products lose patent protection in the coming years. The acquisitions could help the companies add new sales to aging line-ups and suggest this year could be a busy one for industry dealmaking.
Better management of customer data could help pharmaceutical companies’ digital transformation, according to Veeva’s Rebecca Silver. One of the noticeable effects of this has been a massive uptake of remote working across the industry, which has accentuated difficulties in conducting remote sales engagements due to poor customer data quality.
Takeda has joined the ranks of big pharmacompanies jettisoning consumer health businesses in order to concentrate on higher-margin prescription drugs. Takeda Consumer Healthcare sells OTC medicines and other health products with sales of 60 billion yen ($567 million) in fiscal 2019.
They expect and want more from HCPs and pharmacompanies. The medical industry is shifting from a model that revolves around sales reps to an omnichannel world in which HCPs are able to access information as and when they need it. A small biotech company may benefit more from hyper-targeted marketing than omnichannel.
A leading pharmacompany recently sponsored a series of Q&A around the use of their new cancer drug. HCPs rely more on their laptops and tablets, but the last thing they want is pharma busting down the door to sell their products. Social media targeted at HCPs is also a great way to educate physicians.
Pharma has two problems when it come to online health information: 1ne : The information is often too hard to understand for online health seekers. 2wo : Pharma websites are seen as a sales tool rather than a patient tool. Pharma marketers are too often lulled into a false sense of success when looking at raw traffic numbers.
French healthcare and pharmacompany Sanofi will terminate an undisclosed number of positions in its U.S. vaccines commercial unit in an effort to streamline the strategic sales structure.
It was a move, in their minds, from fast-moving biotech to a bureaucratic, slow-moving big pharmacompany. The culture between the two companies is hugely different. It’s doubtful, given the sales of Celgene products, one of which is coming off-patent soon, have not lived up to their “sales pitch.”
The politics of working with a major pharmacompany can be a difficult challenge. There is still much to emphasis on doing things that deliver sales rather than helping patients. I’m surprised that an agency hasn’t developed an app to monitor social media posts around certain keywords for pharma.
What is the definition of a successful pharma product launch? Usually, it’s reaching a certain sales level within a specified time, but that metric is not relevant anymore. Pharmacompanies have been investing deeply into digital advertising but vastly under measuring customer engagement and other metrics.
Valneva has bolstered its vaccines pipeline with a shot designed to protect against shigellosis – a major global health threat – licensed from LimmaTech Biologics.The French pharmacompany – best known for its COVID-19 jab and recent approval for the world's first chikungunya vaccine Ixchiq – is paying €10 million upfront for a stake in LimmaTech's (..)
Long after COVID is a bad memory, the pharma industry will still be making more and more mistakes in the name of profits. I keep talking to pharma old-timers who talk about the “good old days” of working in an industry when sales, and profits, were instrumental in every decision we made.
SUMMARY: Doctors said they were dissatisfied were marketing emails (46%), telephone sales calls with sales reps (42%), and both webinars and websites (each at 39%) from pharmacompanies, according to Indegene. It can’t be promotional or sales information and should not be a long document. 100 percent of U.S.
I’ve seen some new energy and thinking taking root in some big pharmacompanies. Still, I’m also seeing some recycled executives show up at other companies when they should have been removed permanently from the industry. John worked for a division of a major pharmacompany in Cambridge.
WHAT NOW: The idea that most pharmacompanies are here to serve patients is a canard. Pharma CEO’s serve themselves with big salaries tied to drug prices and keeping drugs from coming off patent. And by the time Alles left the company late last year, after its sale to Bristol-Myers Squibb, a single Revlimid pill cost $763.
Most of the US insulin market is controlled by three pharmacompanies: Sanofi, Eli Lilly, and Novo Nordisk. For almost all their insulin, these companies manufacture the API and finished dose in-house and package the products themselves instead of using CMOs, GlobalData’s Drugs database shows.
The top ten pharmacompanies in 2023 by revenue accounted for about 35 percent of the market value, with total earnings of $559.5 The top big pharma players have remained relatively consistent in their market positions over the past several years. Here is a look at the top ten pharmacompanies in 2024 based on 2023 revenue.
Digital channels play a far greater role in communication between pharmacompanies and healthcare professionals than before the pandemic. . INSIGHT: This may be true now but pharmacompanies are ramping up and planning new drug launches in person once the pandemic metrics improve. Medscape Detailed Findings.
Soon they decided that their office in Westin wasn’t good enough for a company with such a sterling reputation, so they spent a massive amount of money building an HQ in Cambridge. They became a big pharmacompany and lost some of the people who made Biogen such great biotech. 4our: The FDA advisors and Aduhelm.
In today’s competitive pharma landscape, success goes beyond meeting quotas. Forward-thinking companies need to adopt AI-powered tools to make informed smarter decisions, strengthen relationships with HCPs, increase sales performance, and optimize the sales reps time in the field
Pharmacompanies are increasing digital budgets, but they are wasting too much money because of internal staffing issues and inexperience with online marketing. ” Too many DTC marketing people have come from the sales force and have a sales mentality at a time when people don’t want the hard sales pitch.
A sales representative for a biotech company shared information with oncologists about patients’ attitudes towards treatment options, including the company’s brand. A pharmacompany that silos DTC from HCP marketing people is disadvantaged.
Only a limited number of international pharmacompanies, however, operate manufacturing sites in the country. Large Brazilian pharmacompanies already play a major role in distributing Covid-19 vaccines to all of Latin America. French and Italian manufacturers have two companies in Brazil.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content